title: Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.
abstract: 2B4 (CD244) is an important activating receptor for the regulation of natural killer (NK) cell responses. Here we show that 2B4 is heavily and differentially glycosylated in primary human NK cells and NK cell lines. The differential glycosylation could be attributed to sialic acid residues on N- and O-linked carbohydrates. Using a recombinant fusion protein of the extracellular domain of 2B4, we demonstrate that N-linked glycosylation of 2B4 is essential for the binding to its ligand CD48. In contrast, sialylation of 2B4 has a negative impact on ligand binding, as the interaction between 2B4 and CD48 is increased after the removal of sialic acids. This was confirmed in a functional assay system, where the desialylation of NK cells or the inhibition of O-linked glycosylation resulted in increased 2B4-mediated lysis of CD48-expressing tumor target cells. These data demonstrate that glycosylation has an important impact on 2B4-mediated NK cell function and suggest that regulated changes in glycosylation during NK cell development and activation might be involved in the regulation of NK cell responses.
authors: Institute for Immunology, University Heidelberg, 69120 Heidelberg, Germany.
authors: Stefanie
authors: S
authors: Margraf-Schönfeld
authors: Carolin
authors: C
authors: Böhm
authors: Carsten
authors: C
authors: Watzl
references: Nat Immunol. 2008 May;9(5):495-502
references: 18425106
references: J Exp Med. 1998 Dec 7;188(11):2083-90
references: 9841922
references: Immunity. 2001 Dec;15(6):1051-61
references: 11754824
references: Front Biosci. 2008 Jan 01;13:956-65
references: 17981603
references: J Biol Chem. 1996 May 3;271(18):10793-9
references: 8631891
references: Blood. 2006 Jan 1;107(1):159-66
references: 16150947
references: Eur J Immunol. 2007 Jan;37(1):193-8
references: 17171759
references: Glycobiology. 2009 May;19(5):527-36
references: 19218400
references: Immunity. 2007 Oct;27(4):572-84
references: 17950006
references: Annu Rev Immunol. 2005;23:225-74
references: 15771571
references: J Immunol. 1994 Jan 15;152(2):397-404
references: 8283028
references: Cell. 2010 May 28;141(5):897-907
references: 20510933
references: J Immunol. 2000 Oct 1;165(7):3545-8
references: 11034353
references: J Exp Med. 2005 Oct 3;202(7):1001-12
references: 16203869
references: EMBO J. 2004 Jan 28;23(2):255-9
references: 14685277
references: Eur J Immunol. 2000 Mar;30(3):787-93
references: 10741393
references: J Biol Chem. 1981 Jul 10;256(13):6633-40
references: 7240233
references: Blood. 2005 Jun 15;105(12):4722-9
references: 15713798
references: J Immunol. 1998 Dec 1;161(11):5809-12
references: 9834056
references: Glycobiology. 2005 Jul;15(7):667-76
references: 15703304
references: J Immunol. 2005 Aug 15;175(4):2045-9
references: 16081768
references: Nat Rev Immunol. 2006 Jan;6(1):56-66
references: 16493427
references: Cell. 2006 Sep 8;126(5):855-67
references: 16959566
references: Biochemistry. 1998 May 12;37(19):6833-7
references: 9578569
references: J Immunol Methods. 2005 Jan;296(1-2):149-58
references: 15680159
references: Int Immunol. 2010 Mar;22(3):167-77
references: 20089585
references: J Biol Chem. 1995 Jan 6;270(1):369-75
references: 7529232
references: Immunology. 2009 Sep;128(1 Suppl):e621-31
references: 19740323
references: J Immunol. 2005 Jul 15;175(2):1005-13
references: 16002700
references: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6329-34
references: 17395718
references: Mol Immunol. 2000 Jun;37(9):493-501
references: 11163399
references: J Immunol. 1999 Jun 15;162(12):6981-5
references: 10358138
references: Annu Rev Immunol. 2001;19:197-223
references: 11244035
references: J Exp Med. 2003 Jan 6;197(1):77-85
references: 12515815
references: Biol Chem. 2009 Jul;390(7):557-65
references: 19426132
references: Semin Immunol. 2004 Dec;16(6):409-19
references: 15541655